Unique ID issued by UMIN | UMIN000041935 |
---|---|
Receipt number | R000047826 |
Scientific Title | Examination of the effects of Euglena intake by young children |
Date of disclosure of the study information | 2020/09/30 |
Last modified on | 2021/09/01 13:26:56 |
Examination of the effects of Euglena intake by young children
Examination of the effects of Euglena intake by young children
Examination of the effects of Euglena intake by young children
Examination of the effects of Euglena intake by young children
Japan |
healthy individuals
Child |
Others
NO
Examination the effects of the test food on atopic dermatitis, bowel movement, sleep quality and quality of life in young children
Safety,Efficacy
Atopic Dermatitis dermatitis symptoms (subjective and objective parameters)
Safety (harmful events, urine items)
Bowel status
Physical condition
Physical examination
DHEA-S in saliva
Melatonin in saliva
Electroencephalogram during sleep
Autonomic nerves activities during sleep
Attention test
Questionnaires (oral cavity, health condition, basic lifestyle, sociality)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Euglena Gracilis powder-containing drink
1 | years-old | <= |
6 | years-old | > |
Male and Female
(1) Healthy infant subjects aged 1 to 6 years
(2) Subjects suffering from atopic dermatitis
(3) Parents or legal guardians voluntarily volunteer for the subject to participate in the exam after the subject's parents or legal guardians fully understand the purpose and content of this exam
(1) Persons with a history of other diseases that may affect the results of this study, such as liver disease, renal disease, digestive system disease, respiratory disease, heart disease, blood disease, endocrine and metabolism, or surgery History subjects
(2) Persons with a disease requiring constant medication, subjects with a history of serious illness requiring medication
(3) Subjects with food and drug allergies
(4) Subject who routinely ingests functional foods and supplements that may affect the excretion of harmful substances in the body
(5) Those who play intense sports and subjects who are on a diet
(6) Subjects who have participated in clinical trials or long-term clinical trials of foods and cosmetics within 4 weeks, and subjects who are currently participating in clinical trials
(7) Other subjects judged by the investigator to be inappropriate
15
1st name | Naoki |
Middle name | |
Last name | Miura |
Miura Clinic, Medical Corporation Kanonkai
Internal medicine
530-0044
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka,Osaka
0661355200
info@miura-cl.jp
1st name | Makoto |
Middle name | |
Last name | Terashima |
Oneness Support Co., Ltd.
Clinical Trial Division
530-0044
Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka
0648018917
mterashima@oneness-sup.co.jp
Miura Clinic, Medical Corporation Kanonkai
euglena Co.,Ltd.
Profit organization
Miura Clinic, Medical Corporation Kanonkai IRB
Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka, Osaka
0661355200
mterashima@oneness-sup.co.jp
NO
医療法人花音会みうらクリニック
2020 | Year | 09 | Month | 30 | Day |
Unpublished
Preinitiation
2020 | Year | 09 | Month | 17 | Day |
2020 | Year | 09 | Month | 17 | Day |
2020 | Year | 10 | Month | 01 | Day |
2020 | Year | 12 | Month | 31 | Day |
2020 | Year | 09 | Month | 29 | Day |
2021 | Year | 09 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047826
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |